These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21122657)

  • 21. Clinical use of ezetimibe.
    Cheng AY; Leiter LA
    Can J Clin Pharmacol; 2003; 10 Suppl A():21A-5A. PubMed ID: 14571302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
    Ghafoorunissa
    Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of statin therapy in adults with coronary heart disease.
    Wilt TJ; Bloomfield HE; MacDonald R; Nelson D; Rutks I; Ho M; Larsen G; McCall A; Pineros S; Sales A
    Arch Intern Med; 2004 Jul; 164(13):1427-36. PubMed ID: 15249352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy.
    Miettinen TA
    Int J Clin Pract; 2001 Dec; 55(10):710-6. PubMed ID: 11777299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of plant sterols in combination with other cholesterol-lowering foods.
    Jenkins DJ; Kendall CW; Nguyen TH; Marchie A; Faulkner DA; Ireland C; Josse AR; Vidgen E; Trautwein EA; Lapsley KG; Holmes C; Josse RG; Leiter LA; Connelly PW; Singer W
    Metabolism; 2008 Jan; 57(1):130-9. PubMed ID: 18078870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In face of the increasing efficacy of lipid-lowering therapy, is there still a place for LDL-apheresis?
    Stegmayr B; Lalau JD; Johnson O
    Transfus Apher Sci; 2004 Jun; 30(3):213-20. PubMed ID: 15172626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel therapeutic approach to dyslipidemia.
    Clearfield MB
    J Am Osteopath Assoc; 2003 Jan; 103(1 Suppl 1):S16-20. PubMed ID: 12572626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ezetimibe: new preparation. A cholesterol-lowering drug with no clinical advantage.
    Prescrire Int; 2004 Oct; 13(73):176-9. PubMed ID: 15499698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
    Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive lipid-lowering therapy: a clinical imperative.
    Pedersen TR
    Eur Heart J; 1998 Oct; 19 Suppl M():M15-21. PubMed ID: 9821012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
    Robinson JG; Smith B; Maheshwari N; Schrott H
    J Am Coll Cardiol; 2005 Nov; 46(10):1855-62. PubMed ID: 16286171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol-lowering effects of oat β-glucan.
    Othman RA; Moghadasian MH; Jones PJ
    Nutr Rev; 2011 Jun; 69(6):299-309. PubMed ID: 21631511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Session 4: CVD, diabetes and cancer: A dietary portfolio for management and prevention of heart disease.
    Esfahani A; Jenkins DJ; Kendall CW
    Proc Nutr Soc; 2010 Feb; 69(1):39-44. PubMed ID: 19968904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia.
    Jenkins DJ; Kendall CW; Faulkner DA; Nguyen T; Kemp T; Marchie A; Wong JM; de Souza R; Emam A; Vidgen E; Trautwein EA; Lapsley KG; Holmes C; Josse RG; Leiter LA; Connelly PW; Singer W
    Am J Clin Nutr; 2006 Mar; 83(3):582-91. PubMed ID: 16522904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.